DENVER - PRESS RELEASE - MedPharm Research, the leader in cannabis research and formulation development, was notified by the Drug Enforcement Administration (DEA) that it had been selected to move forward as one of the first applicants to be granted a license to grow federally legal cannabis under the terms of a new policy statement issued today in the Federal Register. "This is something we have been waiting for since we first sent in our application in September, 2016, as one of the first med...
Browse Article Categories
Colorado's MedPharm Clears Significant DEA Hurdle for Federal Cannabis Research License
Rate this article
No Comments Yet
Be the first to share what you think!